慢性前列腺炎/慢性盆腔疼痛综合征与勃起功能障碍的临床预测

目的应用临床指标,预测慢性前列腺炎/慢性盆腔疼痛综合征（CP/CPSS）发生勃起功能障碍（ED）的可能性。方法以90例门诊确诊的慢性前列腺炎/慢性盆腔疼痛综合征患者为研究对象,分为发生ED组（A组）23例,未发生ED组（B组）67例,分别比较两组间在硫酸脱氢表雄酮（DHEAS）、24h尿香草扁桃体酸（VMA）、年龄等观察指标上的差异性,寻找其中能用于预测ED的临床指标。结果A组平均DHEAS值低于B组,VMA值高于B组,年龄方面两组差异无统计学意义。结论可通过DHEAS、VMA来预测慢性前列腺炎/慢性盆腔疼痛综合征患者ED的发生,有利于对慢性前列腺炎/慢性盆腔疼痛综合征发生ED患者的监控和治疗干预。

The clinical prediction of the erectile dysfunction in chronic prostatitis/chronic pelvic pain syndrome

Objective To predict the incidence of erectile dysfunction(ED) in the patients with chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS) by clinical measures.Methods According to the occurrence of ED,90 CP/CPPS patients were divided into 2 groups.Group A included 23 cases of CP/CPPS with ED,while group B,the remaining 67 of CP/CPPS without ED.The indexes of DHEAS,VMA and age between two groups were compared.Results The average values of DHEAS in group A were significantly lower than in group B(P<0.05),while VMA was higher in group A than in group B(P<0.05).There was no significant difference in age between two groups.Conclusion The occurrence of ED in CP/CPPS may be predicted by DHEAS and VMA.